$XENE Xenon Pharmaceuticals Inc. Insider Trading Week 37/2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Xenon Pharmaceuticals Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Xenon Pharmaceuticals Inc. in week 37/2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 20 2019 | XENE | Xenon Pharmaceutic ... | HOLLER FRANK A | Director | Sell | S | 9.39 | 5,206 | 48,884 | 118,955 | 124.2 K to 119 K (-4.19 %) |
| Sep 20 2019 | XENE | Xenon Pharmaceutic ... | HOLLER FRANK A | Director | Sell | S | 9.27 | 7,600 | 70,452 | 124,161 | 131.8 K to 124.2 K (-5.77 %) |
| Sep 18 2019 | XENE | Xenon Pharmaceutic ... | TARNOW MICHAEL M | Director | Option Exercise | A | 9.44 | 15,000 | 141,600 | 15,000 | |
| Sep 18 2019 | XENE | Xenon Pharmaceutic ... | Svoronos Dawn | Director | Option Exercise | A | 9.44 | 15,000 | 141,600 | 15,000 | |
| Sep 18 2019 | XENE | Xenon Pharmaceutic ... | ROBIN SHERRINGTON | EVP, Strategy & Inn ... | Option Exercise | A | 9.44 | 45,000 | 424,800 | 45,000 | |
| Sep 18 2019 | XENE | Xenon Pharmaceutic ... | SCHELLER RICHARD H | Director | Option Exercise | A | 9.44 | 15,000 | 141,600 | 15,000 | |
| Sep 18 2019 | XENE | Xenon Pharmaceutic ... | PIMSTONE SIMON N. | CEO | Option Exercise | M | 3.38 | 12,345 | 41,726 | 0 | |
| Sep 18 2019 | XENE | Xenon Pharmaceutic ... | PIMSTONE SIMON N. | CEO | Option Exercise | M | 3.07 | 9,259 | 28,425 | 0 | |
| Sep 18 2019 | XENE | Xenon Pharmaceutic ... | PIMSTONE SIMON N. | CEO | Option Exercise | M | 3.70 | 36,008 | 133,230 | 0 | |
| Sep 18 2019 | XENE | Xenon Pharmaceutic ... | PIMSTONE SIMON N. | CEO | Option Exercise | A | 9.44 | 280,000 | 2,643,200 | 280,000 | |
| Sep 18 2019 | XENE | Xenon Pharmaceutic ... | PIMSTONE SIMON N. | CEO | Payment of Exercise | F | 9.44 | 3,692 | 34,852 | 268,517 | 272.2 K to 268.5 K (-1.36 %) |
| Sep 18 2019 | XENE | Xenon Pharmaceutic ... | PIMSTONE SIMON N. | CEO | Buy | M | 3.38 | 12,345 | 41,726 | 272,209 | 259.9 K to 272.2 K (+4.75 %) |
| Sep 18 2019 | XENE | Xenon Pharmaceutic ... | PIMSTONE SIMON N. | CEO | Payment of Exercise | F | 9.44 | 2,769 | 26,139 | 259,864 | 262.6 K to 259.9 K (-1.05 %) |
| Sep 18 2019 | XENE | Xenon Pharmaceutic ... | PIMSTONE SIMON N. | CEO | Buy | M | 3.07 | 9,259 | 28,425 | 262,633 | 253.4 K to 262.6 K (+3.65 %) |
| Sep 18 2019 | XENE | Xenon Pharmaceutic ... | PIMSTONE SIMON N. | CEO | Payment of Exercise | F | 9.44 | 10,769 | 101,659 | 253,374 | 264.1 K to 253.4 K (-4.08 %) |
| Sep 18 2019 | XENE | Xenon Pharmaceutic ... | PIMSTONE SIMON N. | CEO | Buy | M | 3.70 | 36,008 | 133,230 | 264,143 | 228.1 K to 264.1 K (+15.78 %) |
| Sep 18 2019 | XENE | Xenon Pharmaceutic ... | PATOU GARY | Director | Option Exercise | A | 9.44 | 15,000 | 141,600 | 15,000 | |
| Sep 18 2019 | XENE | Xenon Pharmaceutic ... | MORTIMER IAN | PRESIDENT & CFO | Option Exercise | A | 9.44 | 135,000 | 1,274,400 | 135,000 | |
| Sep 18 2019 | XENE | Xenon Pharmaceutic ... | HOLLER FRANK A | Director | Option Exercise | A | 9.44 | 15,000 | 141,600 | 15,000 | |
| Sep 18 2019 | XENE | Xenon Pharmaceutic ... | HOLLER FRANK A | Director | Sell | S | 9.28 | 4,368 | 40,535 | 131,761 | 136.1 K to 131.8 K (-3.21 %) |
| Sep 18 2019 | XENE | Xenon Pharmaceutic ... | HOLLER FRANK A | Director | Sell | S | 9.32 | 5,069 | 47,243 | 136,129 | 141.2 K to 136.1 K (-3.59 %) |
| Sep 18 2019 | XENE | Xenon Pharmaceutic ... | Hayden Michael R | Director | Option Exercise | A | 9.44 | 15,000 | 141,600 | 15,000 | |
| Sep 18 2019 | XENE | Xenon Pharmaceutic ... | GANNON STEVEN | Director | Option Exercise | A | 9.44 | 15,000 | 141,600 | 15,000 | |
| Sep 18 2019 | XENE | Xenon Pharmaceutic ... | EMPFIELD JAMES R. | SVP, Drug Discovery | Option Exercise | A | 9.44 | 40,000 | 377,600 | 40,000 | |
| Sep 18 2019 | XENE | Xenon Pharmaceutic ... | AYCARDI-FONSECA ERNESTO | CMO | Option Exercise | A | 9.44 | 65,000 | 613,600 | 65,000 | |
| Sep 17 2019 | XENE | Xenon Pharmaceutic ... | AZAB MOHAMMAD | Director | Option Exercise | A | 9.44 | 15,000 | 141,600 | 15,000 | |
| Sep 17 2019 | XENE | Xenon Pharmaceutic ... | AZAB MOHAMMAD | Director | Sell | S | 9.31 | 23 | 214 | 57,561 | 57.6 K to 57.6 K (-0.04 %) |